Trials / Unknown
UnknownNCT01693042
Compare the Effects of Single Versus Repeated Intracoronary Application of Autologous Bone Marrow-derived Mononuclear Cells on Mortality in Patients With Chronic Post-infarction Heart Failure
Randomized Controlled Trial to Compare the Effects of Single Versus Repeated Intracoronary Application of Autologous Bone Marrow-derived Mononuclear Cells on Total and SHFM-predicted Mortality in Patients With Chronic Post-infarction Heart Failure
- Status
- Unknown
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 81 (actual)
- Sponsor
- Johann Wolfgang Goethe University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Single or repeated application of autologous bone marrow-derived stem cells to treat chronic post-infarction heart failure
Detailed description
Improve mortality and morbidity in patients with symptomatic chronic post-infarction heart failure under full dose conventional medical and device treatment including resynchronization therapy, by single versus repeated intracoronary infusion of autologous bone marrow-derived mononuclear cells.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | intracoronary infusion of autologous bone marrow-derived cells | Intracoronary infusion into open vessel / bypass supplying previous (\> 3 months) infarct area |
Timeline
- Start date
- 2013-11-01
- Primary completion
- 2022-11-01
- Completion
- 2025-01-01
- First posted
- 2012-09-26
- Last updated
- 2020-02-26
Locations
6 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT01693042. Inclusion in this directory is not an endorsement.